차의과학대학교는 1996년 성광학원에서 설립한 의학특성화 4년제 사립대학으로 차병원그룹이 설립 모체이다.

During the past decade, CHA Bundang Medical Center, CHA University conducted 171 clinical trials. In the 10-year time frame, 171 clinical trials started and 31 clinical trials were completed, i.e. on average, 18.1% percent of trials that started reached the finish line to date. In the past 5 years, 96 clinical trials started and 29 clinical trials were completed. i.e. 30.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CHA Bundang Medical Center, CHA University" #1 sponsor was "CHA University" with 15 trials, followed by "Hoffmann-La Roche" with 13 trials sponsored, "MinYoung Kim, M.D." with 9 trials sponsored, "Bundang CHA Hospital" with 8 trials sponsored and "Seung-Jung Park" with 8 trials sponsored. Other sponsors include 147 different institutions and companies that sponsored additional 93 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHA Bundang Medical Center, CHA University" #1 collaborator was "CardioVascular Research Foundation, Korea" with 14 trials as a collaborator, "Gilead Sciences" with 5 trials as a collaborator, "CHA University" with 4 trials as a collaborator, "Korean Cancer Study Group" with 3 trials as a collaborator and "LG Life Sciences" with 3 trials as a collaborator. Other collaborators include 56 different institutions and companies that were collaborators in the rest 61 trials.

According to Clinical.Site data, the most researched conditions in "CHA Bundang Medical Center, CHA University" are "Cerebral Palsy" (9 trials), "Coronary Artery Disease" (8 trials), "Crohn's Disease" (8 trials), "Healthy" (8 trials) and "Ulcerative Colitis" (8 trials). Many other conditions were trialed in "CHA Bundang Medical Center, CHA University" in a lesser frequency.

Most popular intervention types in "CHA Bundang Medical Center, CHA University" are "Drug" (141 trials), "Biological" (20 trials), "Other" (20 trials), "Device" (13 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Atezolizumab" (7 trials), "Carboplatin" (7 trials), "Gemcitabine" (6 trials) and "Active Rehabilitation" (5 trials). Other intervention names were less common.

The vast majority of trials in "CHA Bundang Medical Center, CHA University" are 187 trials for "All" genders, 12 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 83 active trials in "CHA Bundang Medical Center, CHA University". 1 are not yet recruiting, 53 are recruiting, 24 are Active, not recruiting, and 5 are Enrolling by invitation. In total, there were 83 completed trials in CHA Bundang Medical Center, CHA University, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in CHA Bundang Medical Center, CHA University, 47 "Phase 1" clinical trials were conducted, 39 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 12 trials, and there were also 25 trials that are defined as “Not Applicable".

CHA Bundang Medical Center, CHA University has several departments that took part in Clinical trials: "Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University Health System" - 5 trials, "Yonsei Medical Center; Dept. of Medicine , Division of Hemato-Oncology" - 3 trials, "Department of Rehabilitation Medicine, CHA Bundang Medical Center," - 2 trials